Vinitaa Jha
Overview
Explore the profile of Vinitaa Jha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
28
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhagtani D, Amoutzopoulos B, Steer T, Collins D, Abraham S, Holmes B, et al.
Curr Dev Nutr
. 2025 Feb;
9(2):104543.
PMID: 39991134
Background: South Asia's diverse food supply, food preparations, and eating behaviors require dietary instruments that reflect the consumption patterns of South Asians to enable context specific dietary assessment. Such instruments...
2.
Jain P, Ng H, Tay D, Mina T, Low D, Sadhu N, et al.
medRxiv
. 2025 Feb;
PMID: 39990582
To identify biomarkers and pathways to Type-2 diabetes (T2D), a major global disease, we completed array-based epigenome-wide association in whole blood in 5,709 Asian people. We found 323 Sentinel CpGs...
3.
Pineda E, Atanasova P, Wellappuli N, Kusuma D, Herath H, Segal A, et al.
Lancet Reg Health Southeast Asia
. 2024 Jul;
26:100428.
PMID: 39040122
Background: The increasing prevalence of diet-related non-communicable diseases (NCDs) in South Asia is concerning, with type 2 diabetes projected to rise to 68%, compared to the global increase of 44%....
4.
Kumar S, Delipan R, Chakraborty D, Kanjo K, Singh R, Singh N, et al.
J Virol
. 2023 Oct;
97(11):e0092223.
PMID: 37861334
The Omicron subvariants have substantially evaded host-neutralizing antibodies and adopted an endosomal route of entry. The virus has acquired several mutations in the receptor binding domain and N-terminal domain of...
5.
Budhiraja S, Dewan A, Aggarwal R, Singh O, Juneja D, Pathak S, et al.
Blood Cells Mol Dis
. 2021 Feb;
88:102548.
PMID: 33621948
Background: Convalescent plasma (CP) is being used as a treatment option in hospitalized patients with COVID-19. Till date, there is conflicting evidence on efficacy of CP in reducing COVID-19 related...